Genoray Co., Ltd.

KOSDAQ:A122310 Stock Report

Market Cap: ₩76.7b

Genoray Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Genoray.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth35.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Genoray's (KOSDAQ:122310) Soft Earnings Are Actually Better Than They Appear

Nov 21
Genoray's (KOSDAQ:122310) Soft Earnings Are Actually Better Than They Appear

Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems

Mar 28
Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems

Does Genoray Co., Ltd. (KOSDAQ:122310) Have A Place In Your Dividend Portfolio?

Apr 12
Does Genoray Co., Ltd. (KOSDAQ:122310) Have A Place In Your Dividend Portfolio?

Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?

Mar 01
Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?

We Like Genoray's (KOSDAQ:122310) Returns And Here's How They're Trending

Feb 11
We Like Genoray's (KOSDAQ:122310) Returns And Here's How They're Trending

Is Genoray Co., Ltd.'s (KOSDAQ:122310) Recent Performance Tethered To Its Attractive Financial Prospects?

Jan 27
Is Genoray Co., Ltd.'s (KOSDAQ:122310) Recent Performance Tethered To Its Attractive Financial Prospects?

Is Genoray Co., Ltd. (KOSDAQ:122310) A Smart Choice For Dividend Investors?

Jan 12
Is Genoray Co., Ltd. (KOSDAQ:122310) A Smart Choice For Dividend Investors?

Genoray Co., Ltd. (KOSDAQ:122310) Looks Interesting, And It's About To Pay A Dividend

Dec 24
Genoray Co., Ltd. (KOSDAQ:122310) Looks Interesting, And It's About To Pay A Dividend

A Look At The Fair Value Of Genoray Co., Ltd. (KOSDAQ:122310)

Dec 15
A Look At The Fair Value Of Genoray Co., Ltd. (KOSDAQ:122310)

We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt

Nov 30
We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Genoray has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A122310 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024108,9677,634-2417,164N/A
6/30/2024108,42410,2445456,975N/A
3/31/2024103,60512,597-1,6746,007N/A
12/31/202397,89712,486-5,0443,555N/A
9/30/202392,30012,794-12,7653,170N/A
6/30/202385,47012,315-10,8635,051N/A
3/31/202383,22512,945-1,34413,170N/A
12/31/202282,60413,9001,05714,837N/A
9/30/202283,33614,87415,20921,454N/A
6/30/202283,96415,66312,75718,948N/A
3/31/202278,64314,7459,23416,289N/A
12/31/202174,29014,3236,47515,383N/A
9/30/202164,50211,0573,69511,903N/A
6/30/202163,25910,3279,05017,078N/A
3/31/202162,14510,0074,67511,571N/A
12/31/202061,68810,1724,2288,507N/A
9/30/202067,86213,2605,1779,567N/A
6/30/202067,05213,7881,1805,915N/A
3/31/202066,46914,1425,67910,566N/A
12/31/201965,10613,2405,82610,655N/A
9/30/201959,34511,8593,4488,047N/A
6/30/201955,97510,0581,5056,300N/A
3/31/201956,5679,659-144,688N/A
12/31/201856,2899,4722,6976,893N/A
9/30/201853,1898,3231,5135,697N/A
6/30/201851,0837,490N/A7,996N/A
3/31/201846,0555,741N/A6,450N/A
12/31/201744,4925,170N/A4,472N/A
12/31/201638,2783,225N/A3,473N/A
12/31/201531,8801,997N/A2,100N/A
12/31/201428,569956N/A3,272N/A
12/31/201330,475437N/A985N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A122310's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A122310's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A122310's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A122310's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A122310's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A122310's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y